Publications by authors named "Jan Bultas"

Claim this Profile
[
[Inflammation and vascular diseases].
Debora Karetová, Jan Bultas

Vnitr Lek· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only?].
Debora Karetová, Josef Suchopár, Jan Bultas

Vnitr Lek· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Are proton pump inhibitors an effective and safe drug not only in the prophylaxis of gastrointestinal bleeding in antithrombotic treatment?].
Jan Bultas

Vnitr Lek· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anticoagulant therapy in the elderly].
Debora Karetová, Jan Bultas

Vnitr Lek· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mountain sickness].
Jan Bultas

Cas Lek Cesk· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Anticoagulant therapy in secondary prevention of coronary events].
Jan Bultas

Vnitr Lek· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Extended options of anticoagulant treatment in thromboembolism].
Debora Karetová, Jan Bultas

Vnitr Lek· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacogenetics in cardiovascular diseases therapy--treatment according guidelines or according the individual requirement?].
Jan Bultas

Cas Lek Cesk· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?
John E Deanfield, Phillipe Sellier, Erik Thaulow, Jan Bultas, Carla Yunis

Eur Heart J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between cardiac energy metabolism and gain of left ventricular mass in Fabry disease.
Tomas Palecek, Jan Bultas, Milan Hajek, Debora Karetova, Petr Kuchynka

Int J Cardiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.
Raphael Schiffmann, David G Warnock, Maryam Banikazemi, Jan Bultas, Gabor E Linthorst

Nephrol Dial Transplant· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and progression of the Anderson-Fabry disease related cardiomyopathy.
Christoph Kampmann, Ales Linhart, Frank Baehner, Tomas Palecek, Christiane M Wiethoff, Jan Bultas

Int J Cardiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right ventricular involvement in Fabry disease.
Tomas Palecek, Gabriela Dostalova, Petr Kuchynka, Debora Karetova, Jan Bultas

J Am Soc Echocardiogr· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease.
Joe T R Clarke, Michael L West, Jan Bultas, Raphael Schiffmann

Genet Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.
Miroslav Merta, Jana Reiterova, Jana Ledvinova, Helena Poupetová, Robert Dobrovolny, Jan Bultas

Nephrol Dial Transplant· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
Maryam Banikazemi, Jan Bultas, Stephen Waldek, William R Wilcox, Chester B Whitley

Ann Intern Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.
Christine M Eng, Dominique P Germain, Maryam Banikazemi, David G Warnock, Christoph Wanner, Jan Bultas

Genet Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition.
Frédéric Barbey, Noureddine Brakch, Ales Linhart, Nathalie Rosenblatt-Velin, Xavier Jeanrenaud, Jan Bultas

Arterioscler Thromb Vasc Biol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease.
Frédéric Barbey, Noureddine Brakch, Ales Linhart, Xavier Jeanrenaud, Thomas Palecek, Jan Bultas

Acta Paediatr Suppl· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.
Tomas Palecek, Ales Linhart, Jean Claude Lubanda, Sudheera Magage, Debora Karetova, Jan Bultas

Heart Vessels· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.
Robert Dobrovolny, Lenka Dvorakova, Jana Ledvinova, Sudheera Magage, Jan Bultas

J Mol Med (Berl)· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence of Fabry disease as a result of paternal germline mosaicism for alpha-galactosidase a gene mutation.
Robert Dobrovolný, Lenka Dvoráková, Jana Ledvinová, Sudheera Magage, Jan Bultas

Am J Med Genet A· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male.
Sudheera Magage, Ales Linhart, Jan Bultas, Jan Vojacek, Martin Mates

Echocardiography· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of early diastolic mitral annular velocity and flow propagation velocity in detection of mild to moderate left ventricular diastolic dysfunction.
Tomas Palecek, Ales Linhart, Jan Bultas, Michael Aschermann

Eur J Echocardiogr· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
John E Deanfield, Jean-Marie Detry, Philippe Sellier, Paul R Lichtlen, Eric Thaulow, Jan Bultas

J Am Coll Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis